The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients

[1]  W. Chung,et al.  MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer , 2018, Genetics in Medicine.

[2]  T. Walsh,et al.  Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women , 2017, JAMA oncology.

[3]  S. Ladelund,et al.  Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types , 2017, British Journal of Cancer.

[4]  Alain Viari,et al.  Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency. , 2017, Cancer research.

[5]  A. Chakravarti,et al.  Abstract 4755: Calpastatin phosphorylation regulates radiation response in glioblastoma , 2017 .

[6]  C. Gau,et al.  Multigene Panel Testing Provides a New Perspective on Lynch Syndrome. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. S. Guraya,et al.  Breast cancer screening programs: Review of merits, demerits, and recent recommendations practiced across the world , 2016, Journal of microscopy and ultrastructure.

[8]  P. Ang,et al.  Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore , 2016, npj Genomic Medicine.

[9]  Christopher D. Heinen,et al.  Milestones of Lynch syndrome: 1895–2015 , 2015, Nature Reviews Cancer.

[10]  Aung Ko Win,et al.  Risk of breast cancer in Lynch syndrome: a systematic review , 2013, Breast Cancer Research.

[11]  Markus Loeffler,et al.  Risks of less common cancers in proven mutation carriers with lynch syndrome. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  E. Friedman,et al.  The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer , 2012, Familial Cancer.

[13]  S. Gruber,et al.  High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation. , 2011, Gastroenterology.

[14]  S. Gruber,et al.  Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome , 2011, Clinical genetics.

[15]  E. Friedman,et al.  The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients. , 2010, Gynecologic oncology.

[16]  D. Bercovich,et al.  An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC , 2010, Familial Cancer.

[17]  P. Gregersen,et al.  The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. , 2002, American journal of human genetics.

[18]  P. Dottino,et al.  Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. , 2000, Gynecologic oncology.

[19]  W. Foulkes,et al.  Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. , 1999, Journal of the National Cancer Institute.

[20]  I. Bleiweiss,et al.  Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. , 1998, American journal of human genetics.

[21]  Alfred A. Boyd,et al.  Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.

[22]  E. Friedman,et al.  The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil. , 2016, Cancer genetics.

[23]  E. Friedman,et al.  The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil. , 2016, Cancer genetics.

[24]  Karla Bowles,et al.  Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel , 2015, Cancer.

[25]  L. Norton,et al.  Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. , 1997, Genetic testing.